BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 1727816)

  • 1. Immunoscintigraphy using 111In-labeled F(ab')2 fragments of anticarcinoembryonic antigen monoclonal antibody for detecting recurrences of medullary thyroid carcinoma.
    Vuillez JP; Peltier P; Caravel JP; Chetanneau A; Saccavini JC; Chatal JF
    J Clin Endocrinol Metab; 1992 Jan; 74(1):157-63. PubMed ID: 1727816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioimmunodetection of medullary thyroid carcinoma using indium-111 bivalent hapten and anti-CEA x anti-DTPA-indium bispecific antibody.
    Barbet J; Peltier P; Bardet S; Vuillez JP; Bachelot I; Denet S; Olivier P; Leccia F; Corcuff B; Huglo D; Proye C; Rouvier E; Meyer P; Chatal JF
    J Nucl Med; 1998 Jul; 39(7):1172-8. PubMed ID: 9669389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of colorectal carcinoma by emission-computerized tomography after injection of 123I-labeled Fab or F(ab')2 fragments from monoclonal anti-carcinoembryonic antigen antibodies.
    Delaloye B; Bischof-Delaloye A; Buchegger F; von Fliedner V; Grob JP; Volant JC; Pettavel J; Mach JP
    J Clin Invest; 1986 Jan; 77(1):301-11. PubMed ID: 3484753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoscintigraphy in medullary thyroid cancer using an 123I- or 111In-labelled monoclonal anti-CEA antibody fragment.
    Reiners C; Eilles C; Spiegel W; Becker W; Börner W
    Nuklearmedizin; 1986 Dec; 25(6):227-31. PubMed ID: 3808964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoscintigraphy using 111in-labelled F(ab')2 fragments of anti-carcinoembryonic antigen (CEA) monoclonal antibody for staging of non-small cell lung carcinoma.
    Vuillez JP; Moro D; Brambilla E; Brichon PY; Ferretti G; Saccavini JC; Brambilla C
    Eur J Cancer; 1994; 30A(8):1089-92. PubMed ID: 7654435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-carcinoembryonic antigen antibodies versus somatostatin analogs in the detection of metastatic medullary thyroid carcinoma: are carcinoembryonic antigen and somatostatin receptor expression prognostic factors?
    Behr TM; Gratz S; Markus PM; Dunn RM; Hüfner M; Schauer A; Fischer M; Munz DL; Becker H; Becker W
    Cancer; 1997 Dec; 80(12 Suppl):2436-57. PubMed ID: 9406695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of different scintigraphic techniques to the management of medullary thyroid carcinoma.
    Sandrock D; Blossey HC; Steinroeder M; Munz DL
    Henry Ford Hosp Med J; 1989; 37(3-4):173-4. PubMed ID: 2576957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioimmunodetection of medullary thyroid cancer using a bispecific anti-CEA/anti-indium-DTPA antibody and an indium-111-labeled DTPA dimer.
    Peltier P; Curtet C; Chatal JF; Le Doussal JM; Daniel G; Aillet G; Gruaz-Guyon A; Barbet J; Delaage M
    J Nucl Med; 1993 Aug; 34(8):1267-73. PubMed ID: 8326383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatostatin and somatostatin analogues in medullary thyroid carcinoma.
    O'Byrne KJ; O'Hare N; Sweeney E; Freyne PJ; Cullen MJ
    Nucl Med Commun; 1996 Sep; 17(9):810-6. PubMed ID: 8895910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging lung cancer by scintigraphy with Indium 111-labeled F(ab')2 fragments of the anticarcinoembryonic antigen monoclonal antibody FO23C5.
    Buccheri G; Biggi A; Ferrigno D; D'Angeli B; Vassallo G; Leone A; Taviani M; Comino A
    Cancer; 1992 Aug; 70(4):749-59. PubMed ID: 1643607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging of medullary carcinoma of the thyroid using 111In-labelled anti-CEA monoclonal antibody fragments.
    O'Byrne KJ; Hamilton D; Robinson I; Sweeney E; Freyne PJ; Cullen MJ
    Nucl Med Commun; 1992 Mar; 13(3):142-8. PubMed ID: 1557212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoscintigraphy of colorectal carcinomas with radiolabeled monoclonal antibody fragments.
    Obradovic V; Artiko V; Petrovic M; Stefanovic B; Krivokapic Z; Zuvela M; Stojkovic M; Stefanovic B; Milovanovic A; Vlajkovic M
    Hepatogastroenterology; 2006; 53(70):526-30. PubMed ID: 16995454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoscintigraphy of adenocarcinomas by means of radiolabeled F(ab')2 fragments of an anti-carcinoembryonic antigen monoclonal antibody: a multicenter study.
    Siccardi AG; Buraggi GL; Callegaro L; Colella AC; De Filippi PG; Galli G; Mariani G; Masi R; Palumbo R; Riva P
    Cancer Res; 1989 Jun; 49(11):3095-103. PubMed ID: 2655889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical studies of cancer radioimmunodetection with carcinoembryonic antigen monoclonal antibody fragments labeled with 123I or 99mTc.
    Goldenberg DM; Goldenberg H; Sharkey RM; Higginbotham-Ford E; Lee RE; Swayne LC; Burger KA; Tsai D; Horowitz JA; Hall TC
    Cancer Res; 1990 Feb; 50(3 Suppl):909s-921s. PubMed ID: 2297741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretargeted immunoscintigraphy in patients with medullary thyroid carcinoma.
    Magnani P; Paganelli G; Songini C; Samuel A; Sudati F; Siccardi AG; Fazio F
    Br J Cancer; 1996 Sep; 74(5):825-31. PubMed ID: 8795589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early immunoscintigraphic localisation of a mediastinal tumour with indium 111-DTPA CEA-specific F(ab')2 monoclonal antibody fragments (BW 431/31) using second tracer isocontour technique.
    Frohn J; Baum RP; Happ J; Falk S; Riemann HE; Hör G
    Eur J Nucl Med; 1990; 17(1-2):91-3. PubMed ID: 2083548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoscintigraphy of adenocarcinomas by means of 111In-labelled F(ab')2 fragments of anti-CEA monoclonal antibody F023C5.
    Riva P; Paganelli G; Callegaro L; Bartoli MG; Turci D; Benini S; Deleide G; Scassellati GA; Viale G; Siccardi AG
    Nucl Med Commun; 1988 Aug; 9(8):577-89. PubMed ID: 3173916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioimmunoimaging of metastatic medullary carcinoma of the thyroid gland using an indium-111-labeled monoclonal antibody to CEA.
    Edington HD; Watson CG; Levine G; Tauxe WN; Yousem SA; Unger M; Kowal CD
    Surgery; 1988 Dec; 104(6):1004-10. PubMed ID: 3194829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-step immunoscintigraphy for non-small-cell lung cancer staging using a bispecific anti-CEA/anti-indium-DTPA antibody and an indium-111-labeled DTPA dimer.
    Vuillez JP; Moro D; Brichon PY; Rouvier E; Brambilla E; Barbet J; Peltier P; Meyer P; Sarrazin R; Brambilla C
    J Nucl Med; 1997 Apr; 38(4):507-11. PubMed ID: 9098191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-centre immunoscintigraphic study using indium-111-labelled CEA-specific and/or 19-9 monoclonal antibody F(ab')2 fragments.
    Chetanneau A; Baum RP; Lehur PA; Liehn JC; Perkins AC; Bares R; Bourguet P; Herry JY; Saccavini JC; Chatal JF
    Eur J Nucl Med; 1990; 17(5):223-9. PubMed ID: 2083556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.